Language: 简体中文 English
Quanyi Guo
Quanyi Guo ,  Ph.D
chief surgeon, orthopedics professor, doctoral tutor of the Department of Orthopedics of the General Hospital of PLA,
deputy director of the PLA Orthopedics Institut


【Committee and Broad Memberships】
Subject project expert of Ministry of Science and Technology, "863" biomedical field organization engineering key technology and series product project research and development chief expert of the Ministry of Science and Technology, Member of the Key Specialist Group on National Key Research and Development Program Additive Manufacturing and Laser Manufacturing of the Ministry of Science and Technology of the 13th Five-Year Plan, Member of the Expert Group on Biomaterials of the National Key Research and Development Program of the Ministry of Science and Technology of the 13th Five-Year Plan, Deputy Chairman of the Organization of Rehabilitation and Regeneration Branch of the Chinese Medical Association, Deputy Chairman of the Bone Tissue Organization Branch of the China Medical Biotechnology Association,  the leader of the Cartilage Regeneration Group of the Society of Rehabilitation and Regeneration of the Chinese Medical Association, Standing Committee Member of the Medical Technology Application Management Committee of China Hospital Association, the Vice Chairman of China department of the International Cartilage Repair Section (ICRS), commissioner of  the Basic Section and the Rehabilitation Group of the Chinese Medical Association Orthopedic Branch.

【Scientific research characteristics】
Undertake the “863” project of the Ministry of Science and Technology, Support four Subject Plans, four projects of the National Natural Science Foundation, one project of the Beijing Natural Science Foundation as the first person in charge. Participated in the research and development of key military subjects, published more than 100 papers, including more than 70 SCI articles. Received the first prize of the Science and Technology Progress Award of the whole army, the Beijing Medical Award, and the Huang Jiasi Biomedical Engineering Award. Lead the formulation of the State Food and Drug Administration tissue bank management norms and standards, lead the formulation of relevant standards such as the quality management regulations of the China Biomedical Biotechnology Association cell bank. Participate in the development of international standards for non-invasive nuclear magnetic assessment of international cartilage repair. Originally use the fourth generation tissue engineered cartilage to repair of articular cartilage injury internationally, which brings good news to patients with early articular cartilage injury. During the period of leading key technologies and series of products in the “863” biomedical field of the Ministry of Science and Technology, leaded team to research the development of basic and clinical applications in bones, cartilages, nerves, blood vessels, tendons, hearts and livers. Recycled products and technologies are registered by the State Food and Drug Administration and national clinical application license for medical technology. The monographs included in the compilation include: Orthopedic Surgery, Master's Doctoral Textbook, Surgery Textbook, Huang Jiasi Surgery, and Regenerative Medicine: Basic and Clinical, Regenerative Medicine: Principles and Practice.

【Clinical features】
Conducted clinical research on osteoarthritis, joint degeneration, articular cartilage injury, femoral head necrosis and orthopedic tumor immunotherapy. Firstly used the fourth generation tissue engineered cartilage to repair of articular cartilage injury internationally, which brings good news to patients with early articular cartilage injury. Performed the minimally invasive treatment of femoral head necrosis. Established systematic therapeutic schedule of orthopedic degeneration, strain, sports injury, rehabilitation before and after surgery and physical therapy. Conducted osteoarthritis systemic treatment program combined with joint exercise rehabilitation treatment, enriched platelets, and umbilical cord mesenchymal stem cells.

Abstract:
Medicine and bioengineering integration to solve clinical problems—the story of the combination of bio-manufacturing and orthopedic biomaterials

Throughout the reality of the rapid development of medicine at home and abroad, we can clearly see that most of the laws are lying in the fruits of the integration of medicine and bioengineering. The concept of integrating medicine and bioengineering often appears in the cross-disciplinary field of medicine and bioengineering. It has also become the theme of many medical academic conferences, bio-manufacturing forums, and medicine and bioengineering transformation seminars. Unfortunately, this concept is very difficult to apply to clinical practice as we don't know where to start it.
 The topic of “Medicine and bioengineering integration to solve clinical problems—the story of the integration of bio-manufacturing and orthopedic biomaterials” reveals the clinical problems of the treatment of common diseases osteoarthritis in the Institute of Orthopedics, Chinese PLA General Hospital. It also shows that the cooperation methods and results in artificial joints, articular cartilage damage and meniscus repair are combined through the integration of medicine and bioengineering under different conditions and levels of science and technology.
 The PLA General Hospital is one of the earliest research institutions to develop artificial joints. In the 1970s, artificial joints such as knees, hips, and shoulders were developed in China through the integration of medicine and bioengineering. It improved life quality of many patients with severe osteoarthritis during its clinical application. However, with the clinical application of artificial joints, it could be found that young patients’ artificial joints are prone to loosening after joint replacements. Therefore, the research team carried out research on cartilage tissue engineering in the 1990s. Through the medical background researchers selecting materials and the engineering background researchers assisting in the preparation, the construction of the leading cartilage tissue engineering stent at home and abroad, applied to the clinical solution to the repair problems of articular cartilage injury in young patients. In the aspect of joint meniscus injury, the 3D printed tissue engineering meniscus for the meniscus regeneration has also made a great breakthrough.  
COUNTDOWN
  • DAYS
  • HOURS
  • MINUTES
  • SECONDS
Key Dates
   Deadline for Submission of Abstract:
  October 31, 2018
   Notification of abstract acceptance:
   November 15, 2018